CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+1.27%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.8B
AUM Growth
-$159M
(-3.2%)
Cap. Flow
-$221M
Cap. Flow
% of AUM
-4.61%
Top 10 Holdings %
Top 10 Hldgs %
18.32%
Holding
699
New
64
Increased
242
Reduced
263
Closed
62
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$33.5M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$32.3M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$30.8M |
| 4 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$29.8M |
| 5 |
GAP
The Gap, Inc.
GAP
|
+$25M |
Top Sells
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$40.8M |
| 2 |
Intuit
INTU
|
+$32.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$31.9M |
| 4 |
Mastercard
MA
|
+$28.9M |
| 5 |
Nike
NKE
|
+$27.3M |
Sector Composition
| 1 | Healthcare | 29.43% |
| 2 | Financials | 13.37% |
| 3 | Technology | 9.88% |
| 4 | Consumer Discretionary | 7.77% |
| 5 | Industrials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Karyopharm Therapeutics
KPTI
$54.2M
| $3.62M | 0.08% |
8,867
-9,066
| -51% | -$3.7M |
|
|
ONCE
277
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $3.62M | 0.08% |
60,000
+5,000
| +9% | +$301K |
|
278
Humana
HUM
$37.3B
| $3.53M | 0.07% |
18,458
-3,500
| -16% | -$670K |
|
279
Suncor Energy
SU
$48.8B
| $3.49M | 0.07% |
126,523
-13,715
| -10% | -$378K |
|
280
Larimar Therapeutics
LRMR
$336M
| $3.46M | 0.07% |
8,333
| – | – |
|
|
MRTX
281
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.46M | 0.07% |
110,000
-4,000
| -4% | -$126K |
|
282
Ovintiv
OVV
$10.6B
| $3.44M | 0.07% |
62,324
+15,949
| +34% | +$880K |
|
283
BCE
BCE
$22.7B
| $3.42M | 0.07% |
80,477
-13,526
| -14% | -$575K |
|
284
Puma Biotechnology
PBYI
$230M
| $3.39M | 0.07% |
29,000
+12,000
| +71% | +$1.4M |
|
285
Target
TGT
$41.6B
| $3.38M | 0.07% |
41,420
+9,216
| +29% | +$752K |
|
|
ACHN
286
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $3.37M | 0.07% |
380,000
+25,000
| +7% | +$222K |
|
|
RTN
287
DELISTED
Raytheon Company
RTN
| $3.32M | 0.07% |
34,691
-17,452
| -33% | -$1.67M |
|
288
Walmart
WMT
$815B
| $3.31M | 0.07% |
140,187
+12,486
| +10% | +$295K |
|
289
Lincoln National
LNC
$7.9B
| $3.31M | 0.07% |
55,880
-164,413
| -75% | -$9.74M |
|
290
Scotiabank
BNS
$79.5B
| $3.3M | 0.07% |
66,876
+7,252
| +12% | +$358K |
|
291
Halozyme
HALO
$8.76B
| $3.23M | 0.07% |
143,000
-167,000
| -54% | -$3.77M |
|
|
GTI
292
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
| $3.22M | 0.07% |
+649,866
| New | +$3.22M |
|
293
Kinder Morgan
KMI
$58.8B
| $3.2M | 0.07% |
83,274
+25,644
| +44% | +$985K |
|
294
PTC Therapeutics
PTCT
$4.52B
| $3.18M | 0.07% |
66,000
-31,000
| -32% | -$1.49M |
|
|
RXDX
295
DELISTED
Ignyta, Inc.
RXDX
| $3.17M | 0.07% |
+210,000
| New | +$3.17M |
|
|
XLRN
296
DELISTED
Acceleron Pharma Inc.
XLRN
| $3.16M | 0.07% |
100,000
+32,000
| +47% | +$1.01M |
|
|
GGP
297
DELISTED
GGP Inc.
GGP
| $3.16M | 0.07% |
+123,317
| New | +$3.16M |
|
|
OREX
298
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $3.14M | 0.07% |
63,500
| – | – |
|
|
CMRX
299
DELISTED
Chimerix, Inc.
CMRX
| $3.14M | 0.07% |
68,000
+3,000
| +5% | +$139K |
|
300
Banco Bradesco
BBD
$33.6B
| $3.11M | 0.06% |
721,947
| – | – |
|